LI Chao. Study on the diagnostic value of serum miR-181b and lncRNA MIAT in hypertensive nephropathy. 2025. biomedRxiv.202504.00051
Study on the diagnostic value of serum miR-181b and lncRNA MIAT in hypertensive nephropathy
Corresponding author: LI Chao, 303334361@qq.com
DOI: 10.12201/bmr.202504.00051
-
Abstract: Objective Analyze the diagnostic value of serum microRNA-181b, long non coding RNA (lncRNA) myocardial infarction association transcript (MIAT) in hypertensive nephropathy (HN). Method A total of 120 patients with essential hypertension (EH) who visited our hospital from October 2022 to October 2024 were selected and divided into the HN group (52 cases) and the simple hypertension group (68 cases) based on the ratio of urinary albumin to urinary creatinine. Additionally, 60 healthy individuals who underwent physical examinations during the same period were selected as the control group. The expression levels of miR-181b and lncRNA MIAT in the serum of each group were detected by real-time fluorescence quantitative PCR. The serum inflammatory factor indicators, including high-sensitivity C-reactive protein (hs-CRP),tumor necrosis factor-α(TNF-α), and interleukin-6(IL-6), were detected by enzyme-linked immunosorbent assay.Results The levels of hs-CRP, TNF-α, and IL-6 in the HN group were significantly higher th
Key words: Essential hypertension; Hypertensive nephropathy; MiR-181b; LncRNA MIATSubmit time: 16 April 2025
Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity. -
图表
-
YUE xiaobo, ZHAO Xingsheng. The correlation between serum MHR, NLR, and PLR with essential hypertension. 2024. doi: 10.12201/bmr.202411.00052
ZHANG Xiao-juan. Study on the Prevention and Treatment of Hypertension and Diabetes Mellitus in Community Hospital. 2023. doi: 10.12201/bmr.202311.00002
ZHOU Weiqian, YANG Peng, MO Guojun, OU Hesheng.. Effect of zhuang medicine Adinandra nitida on blood pressure of hypertensive rats induced by L-NAME.. 2025. doi: 10.12201/bmr.202503.00028
XU Jianhong. Study of dexmedetomidine on intestinal barrier protection in hypertensive patients. 2024. doi: 10.12201/bmr.202408.00045
pangzhen, GuJiYu, WuYuFei, YanSshiXing, LiWangYang, SunYue. A study on the solution of the problem of extracting essential substance of TCM diagnosis and treatment of hypertension based on triple extraction strategy. 2021. doi: 10.12201/bmr.202107.00015
zhouyibo, wangxidan, chenjingwan, chenfuhua, taoxiaoying. YANG Daoling, ZHOU Yibo, WANG Xidan, CHEN Jingwan, CHEN Fuhua, TAO XiaoyingFirst-author’s address: Department of Ultrasound Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, China. 2024. doi: 10.12201/bmr.202410.00076
zhou wei. Construction and Analysis of a Prediction Model for Hypertension Combined with Left Ventricular Diastolic Dysfunction Based on Random Forest AlgorithmWANG Tingting1 ,ZHOU Wei1*. 2025. doi: 10.12201/bmr.202503.00046
An Hongwei, Wang Ruixin. The potential value of LncRNA MALAT1 in the treatment of ischemic stroke. 2025. doi: 10.12201/bmr.202506.00007
XIANG Hongying, LING Yingchun. Analysis of the predictive value of quantitative parameters of electroencephalogram and serum miR-146a-5p for cognitive impairment in Alzheimers disease patients. 2024. doi: 10.12201/bmr.202412.00027
Jing ZHAO, Junxia HUANG, Xiuhua TANG, Hong WANG. The role of HOXA11-AS/miR-149-3p pathway in the malignant phenotype of lung squamous cell carcinoma. 2022. doi: 10.12201/bmr.202204.00005
-
ID Submit time Number Download 1 2025-02-06 bmr.202504.00051V1
Download -
-
Public Anonymous To author only
Get Citation
Article Metrics
- Read: 82
- Download: 1
- Comment: 0